Sign In
U.S. Department of Health & Human Services
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Products Purchased by the US Government
Bamlanivimab
Bamlanivimab-etesevimab
emergency-use-authorization
Bebtelovimab
FAQs
emergency-use-authorization
Bebtelovimab Replacement Requests in HPOP: Information for Providers | HHS/ASPR
Evusheld
FAQs
emergency-use-authorization
Lagevrio
FAQs
emergency-use-authorization
Molnupiravir
Lagevrio (molnupiravir) Frequently Asked Questions | HHS/ASPR
Lagevrio (molnupiravir) Emergency Use Authorization | HHS/ASPR
Paxlovid
FAQs
emergency-use-authorization
REGEN-COV
emergency-use-authorization
Sotrovimab
emergency-use-authorization
Veklury
COVID-19 Product Resources | HHS/ASPR
Currently selected
COVID-19 Paused and Discontinued Products: Retention, Storage, and Shelf-Life Extension | HHS/ASPR
Toggle navigation
COVID-19 Therapeutic Product Resources
Resources and Information About COVID-19 Treatments, Guidelines, and Care
General ASPR Resources
COVID-19 Therapeutics Shelf-life Extensions
View the current shelf-life extensions for COVID-19 therapeutic products.
Commercialization of COVID-19 Medical Countermeasures
Learn more about the transition of treatments, vaccines, and test kits to established pathways of procurement, distribution, and payment on the ASPR Commercialization FAQ page.
Federal Response to COVID-19: Therapeutics Clinical Implementation Guide
Read about an overview of the therapeutics, when to use them, their authorizations, and administration guidelines.
COVID-19 Therapeutics Decision Aid
Use the Decision Aid to help identify which treatments are appropriate for your patients.
Side-by-Side Outpatient Therapeutics Overview
Compare details about the outpatient therapeutics available to treat your patients.
Test to Treat
Access lifesaving COVID-19 treatments.
General Resources Across Federal Entities
HHS Bridge Access Program For COVID-19 Vaccines and Treatments
Discover how the federal government will maintain broad access to COVID-19 treatments and vaccines for millions of uninsured Americans.
FDA Emergency Use Authorizations
Read about the current COVID-19 Emergency Use Authorizations.
Health Alert Network (HAN)
Explore HAN, the Center for Disease Control and Prevention’s primary method of sharing cleared information about urgent public health incidents.
National Emerging Special Pathogens Training and Education Center (NETEC)
View resources, training, consulting, and assessments on special pathogen preparedness and response across health systems in the U.S.
NIH COVID‑19 Treatment Guidelines
Review treatment recommendations for clinicians who are caring for patients with COVID-19.
CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
Delve into scientific review documents about each of the therapeutic products.
Telehealth
HHS Fact Sheet May 10, 2023: Telehealth Flexibilities and Resources and the COVID-19 Public Health Emergency
Read about key details of what will change and what will stay the same for patients and providers when the COVID-19 public health emergency ends.
Telehealth.HHS.gov: How to Get or Provide Remote Halth Care
Find out about telehealth for patients and providers.
For Providers | Telehealth.HHS.gov
Discover telehealth resources for health care providers, including doctors, practitioners, and hospital staff.
Health Equity in Telehealth | Telehealth.HHS.gov
Learn about equity and access in telehealth.
Office for the Advancement of Telehealth | HRSA
Explore a variety of telehealth programs from the Health Resources and Services Administration (HRSA).
Telehealth Resource Centers (TRCs) | HRSA
Locate TRCs across the nation, including links to their websites.
Information for Health Care Providers About Patient Management
Clinical Management Summary
Review the therapeutic management of nonhospitalized and hospitalized adults with COVID-19.
General Management of Nonhospitalized Patients With Acute COVID‑19
Learn about the evaluation and management of outpatients with COVID-19.
Therapeutic Management of Nonhospitalized Adults With COVID‑19
Learn about the pharmacologic management of nonhospitalized adults with COVID-19.
Interim Clinical Considerations for COVID-19 Treatment in Outpatients
Find information for health care providers about outpatient treatment options for COVID-19, and factors that increase risk for severe COVID-19.
Testing for SARS-CoV-2 Infection
Read recommendations on testing to diagnose SARS-CoV-2 infection.
CDC’s Increasing Community Access to Testing (ICATT) Program
Discover how ICATT supports no-cost COVID-19 testing for people who are experiencing symptoms related to COVID-19 or have been exposed to someone with COVID-19.
Health Resources and Services Administration (HRSA) Health Centers
About Health Centers | Bureau of Primary Health Care (hrsa.gov)
Become a Health Center and learn about the impact of HRSA’s Health Center Program and the strategic partnerships that support HRSA’s efforts.
Find a Health Center (hrsa.gov)
Use this locator tool to find a Health Center near you.
Locating COVID‑19 Therapeutics
Locating Sites For COVID-19 Treatments
Identify sites of care administering COVID-19 therapies.
Test to Treat Locator
Use this resource to identify sites of care for testing, prescribing, and administering Paxlovid and Lagevrio (molnupiravir).
COVID‑19 Therapeutic Distribution
Read information about the distribution process for COVID-19 therapeutics to state and territorial health departments including thresholds, courses delivered, and courses administered by jurisdiction.
Federal Retail Pharmacy Therapeutics Program (FRPTP)
Learn about the FRPTP program and how it increases COVID-19 therapeutics access and equity across the country.
Ordering COVID‑19 Therapeutics
Process for Ordering COVID‑19 Therapeutics: The Health Partner Ordering Portal (HPOP)
Use HPOP, an ordering portal for requesting and ordering COVID-19 therapeutic products provided at no cost.
ASPR Regional Emergency Coordinators (RECs)
Connect with all levels of government and health care representatives for federal emergency response via RECs.
State & Territorial Health Department Websites
Link to health departments in all 50 states, 8 U.S. territories and freely-associated states, and the District of Columbia.
Reporting Use and Safety Issues for COVID-19 Therapeutics
Reporting Therapeutics in HPOP
Learn how mandatory reporting of all USG-supplied COVID-19 therapeutics must be done in HHS/ASPR's Health Partner Ordering Portal (HPOP) Therapeutics.
MedWatch Online Voluntary Reporting Form
Use these forms to voluntarily report observed or suspected adverse events for human medical products to the U.S. Food and Drug Administration.
Paxlovid (Pfizer) Safety Reporting
Report safety concerns with using Paxlovid.
Lagevrio (molnupiravir) Safety Reporting Email:
dpoc.usa@msd.com
Report safety concerns with using Lagevrio.
Veklury
®
(Gilead) Safety Reporting Email:
Safety_fc@gilead.com
Report safety concerns with using Veklury.
High-Risk Patients and Special Populations
Underlying Medical Conditions Associated with Higher Risk for Severe COVID‑19 Information for Healthcare Professionals
Refer to this evidence-based resource when caring for patients with underlying medical conditions who are at higher risk of developing severe outcomes of COVID-19.
People with Certain Medical Conditions
See a list of medical and underlying conditions that make adults more at risk for COVID-19 and link to more information for each condition.
COVID‑19 Vaccines for People who are Moderately or Severely Immunocompromised
Learn the Center for Disease Control and Prevention's recommendations for COVID-19 vaccines for moderately to severely immunocompromised people.
COVID‑19 Treatment Guidelines for Special Populations: Pregnancy, Children, Cancer, Transplant, HIV, Influenza
Consider these guidelines when managing COVID-19 in pregnant people, people with HIV, and other special patient populations.
Resources for Patients
Quarantine and Isolation
Learn about isolating when you have COVID-19.
COVID.gov
Find COVID-19 guidance for your community.
The Federal Retail Pharmacy Program for COVID‑19 Vaccination
Discover the Federal Retail Pharmacy Program for COVID-19 Vaccination.
Symptoms of COVID‑19
Identify COVID-19 symptoms, when to seek emergency medical attention, the difference between COVID-19 and flu, and print resources and videos.
What to Do if You Are Sick
Find links to information on caring for yourself or others during COVID-19, including symptoms, cleaning, disinfecting, and quarantine and isolation.
Individual COVID-19 Therapeutic Product Resources
Paxlovid
Paxlovid
Visit the Paxlovid webpage to view current information and updates about the therapeutic product.
Paxlovid EUA Resources
Read U.S. Food and Drug Administration resources and health care and patient fact sheets.
Paxlovid Resources from Pfizer
Explore safety information, downloadable resources, and videos about Paxlovid.
ASPR Paxlovid FAQ
Find the answers to some frequently asked questions provided by ASPR.
Paxlovid Drug Interaction Checker
Use this interactive tool to identify any drug interactions with Paxlovid.
Paxlovid Patient Eligibility Screening Checklist Tool for Prescribers
Understand clinical decision making for prescribers with this checklist.
Healthcare Provider Letter about Dispensing Information
Identify contraindications related to drug interactions associated with Paxlovid (nirmatrelvir tablets; ritonavir tablets).
Paxlovid Dispensing Information for Patients with Moderate Renal Impairment
Use this information sheet to see the steps for a pharmacist to dispense Paxlovid for moderate renal impairment.
Dosing and Administration
Find important info about the Paxlovid morning and evening dosing schedule.
Ritonavir-Boosted Nirmatrelvir (Paxlovid) Guidelines
Read about using ritonavir-boosted nirmatrelvir in patients with COVID-19 with NIH’s Paxlovid treatment guide.
Information About State-Licensed Pharmacists Prescribing Paxlovid
Identify how pharmacists can prescribe Paxlovid.
Manufacturer’s Resources for Healthcare Providers
Explore Pfizer’s Paxlovid resources.
Manufacturer’s Resources for Patients
Learn more about Paxlovid from Pfizer.
COVID‑19 Rebound After Paxlovid Treatment
Read the Centers for Disease Control and Prevention’s health advisory about rebound COVID-19.
Pfizer Safety Reporting
Report safety concerns with using Paxlovid.
Lagevrio (molnupiravir)
Lagevrio
Visit the Lagevrio webpage to view current information and updates about the therapeutic product.
Lagevrio EUA Resources
Read the U.S Food and Drug Administration’s resources and health care and patient fact sheets.
ASPR Lagevrio FAQ
Find the answers to some frequently asked questions provided by ASPR.
Molnupiravir Guidelines
Read about using molnupiravir in patients with COVID-19.
Manufacturer Website for Providers
Explore how Lagevrio works and its Emergency Use Authorization.
Manufacturer Website for Patients
Learn about the investigational prescription pill Lagevrio.
Dosing and Administration
Review dosing and administration information for Lagevrio including dosage adjustments and when Lagevrio should be administered.
Lagevrio Safety Reporting Email:
dpoc.usa@msd.com
Report safety concerns with using Lagevrio.
Veklury
®
(Remdesivir)
ASPR Veklury Information
Visit the Veklury webpage to learn more about the therapeutic product.
Veklury (remdesivir) Prescribing Information
Read full prescribing information for Veklury.
Veklury (remdesivir) Guidelines
Learn more about studies investigating remdesivir and how the drug may benefit people with severe COVID-19 disease.
Manufacturer Website for Health Care Providers
Explore Veklury, an antiviral treatment approved by the U.S. Food and Drug Administration for COVID-19.
Veklury (Gilead) Safety Reporting Email:
Safety_fc@gilead.com
Report safety concerns with using Veklury.
Evusheld
Evusheld
Visit the Evusheld webpage to view current information and updates about the therapeutic product.
Evusheld EUA Resources
Read the U.S. Food and Drug Administration resources and health care and patient fact sheets.
ASPR Evusheld FAQ
Find the answers to some frequently asked questions provided by ASPR.
Evusheld Safety Reporting
Report safety concerns with using Evusheld.
AstraZeneca Evusheld HelpLine for Providers:
1-833-EVUSHLD
Bebtelovimab
Bebtelovimab
Visit the Bebtelovimab webpage to view current information and updates about the therapeutic product.
Bebtelovimab EUA Resources
Read the U.S. Food and Drug Administration resources and health care and patient fact sheets.
REGEN-COV
®
REGEN-COV
Visit the REGEN-COV webpage to view current information and updates about the therapeutic product.
REGEN-COV EUA Resources
Read the U.S. Food and Drug Administration resources and health care and patient fact sheets.
Bamlanivimab/Etesevimab
Bamlanivimab/Etesevimab
Visit the Bamlanivimab/Etesevimab webpage to view current information and updates about the therapeutic product.
Bamlanivimab/Etesevimab EUA Resources
Read the U.S. Food and Drug Administration resources and health care and patient fact sheets.
Sotrovimab
Sotrovimab
Visit the Sotrovimab webpage to view current information and updates about the therapeutic product.
Sotrovimab EUA Resources
Read the U.S. Food and Drug Administration resources and health care and patient fact sheets.
COVID-19 Therapeutics Right-Nav
COVID-19 Therapeutics
Locating COVID-19 Therapeutics
Test to Treat
COVID-19 Therapeutics Locator for Providers
COVID-19 Therapeutics Thresholds by Jurisdiction
Product Resources
Product Resources
COVID-19 Therapeutic Product Expiration
Therapeutics Clinical Implementation Guide
COVID-19 Therapeutics Decision Aid
Side-by-Side Outpatient Therapeutics Overview
Information for Long‑Term Care Facilities
Outpatient COVID-19 Therapeutics
Paxlovid
Lagevrio (molnupiravir)
Veklury (remdesivir)
Previously Available Products
Announcements
Important Updates
Social Media Digital Toolkit
